Harry L. Leider, Chief Executive Officer at Organicell Regenerative Medicine, Inc. (OCEL), bought 549,450 shares at $0.01 ($5K) on 2023-06-28, disclosed to the SEC on 2023-12-21.
Open-market purchase of $5k OCEL by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |